Antigenesis
Antigenesis is a biotechnology company focused on addressing critical unmet needs in veterinary medicine by translating proven advances from human therapeutics into the underserved animal health market
Using AI/ML-enabled biologics and deep expertise in antibody engineering, we develop targeted, safe, and effective treatments for serious diseases, starting with oncology.
Our approach builds on validated human immunotherapy principles, allowing us to reduce development risk, accelerate timelines, and deliver first-in-class antibody therapeutics designed specifically for companion animals. By prioritising precision and mechanism-driven biology, we aim to extend both lifespan and quality of life for pets facing life-limiting conditions.
At our core is a simple belief: animals deserve access to the same cutting-edge care as humans. Through rigorous science, responsible innovation, and an ethical development framework, Antigenesis is shaping the future of veterinary medicine and transforming how complex diseases in companion animals are treated.
Visit the website: https://antigenesis-bio.com/